XBIOTECH INC. (XBIT) Free cash flow 2016–2025
XBIOTECH INC. (XBIT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$40.2MFY2025 · since FY2016: -$50.8M → -$40.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$40.2M | -24.6% |
| FY2024 | -$32.3M | -69.1% |
| FY2023 | -$19.1M | -23.9% |
| FY2022 | -$15.4M | -123.4% |
| FY2021 | $65.9M | +195.7% |
| FY2020 | -$68.9M | -272.8% |
| FY2019 | -$18.5M | -10.9% |
| FY2018 | -$16.7M | +52.5% |
| FY2017 | -$35.1M | +30.9% |
| FY2016 | -$50.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice